Constantine A. Stratakis
About Constantine A. Stratakis
Constantine A. Stratakis is a distinguished geneticist known for his research on genetic disorders and his leadership in clinical genetics, including roles as Chief of Clinical Genetics and various prestigious positions in research and academia.
Constantine A. Stratakis: Chief of Clinical Genetics
Constantine A. Stratakis currently holds the position of Chief of Clinical Genetics. He is renowned for his contributions to genetic research, mentorship, and leadership. His work in this field has earned him international recognition and numerous accolades.
Research on Genetic Disorders and Tumors
Constantine A. Stratakis has made significant contributions to the identification of genes connected to various conditions such as height, hypertension, and cancer. He is especially noted for his discoveries related to adrenal and pituitary tumors. His work has elucidated the genetic defects underlying conditions like Carney complex, Carney Triad, and Carney-Stratakis syndrome. Additionally, he described new genetic entities, including X-linked acrogigantism (X-LAG) and the 3 Ps association involving paragangliomas, pheochromocytomas, and PA.
Publications and Editorial Roles
Constantine A. Stratakis is an author of more than 800 scientific publications. His extensive body of work and expertise have led him to serve in major editorial roles for leading scientific journals, further cementing his influence in the genetics and endocrinology communities.
Awards and Honors
Constantine A. Stratakis has received numerous prestigious awards. These include the 1999 Award for Excellence in Published Clinical Research, the 2009 Ernst Oppenheimer Award from the Endocrine Society, and the 2019 Dale Medal from the Society for Endocrinology. He has also been honored with two honorary degrees from the Universities of Liege and Athens.
Leadership and Teaching
Over his career, Constantine A. Stratakis has trained more than 200 trainees and has received multiple awards for his teaching efforts. He served as the President of the Society for Pediatric Research in 2018-2019. He held the position of Scientific Director at the NICHD, NIH from 2009 to 2020, and in 2020, he was appointed as Chief Scientific Officer (CSO) at ELPEN and Director of their new Research Institute on Precision Medicine. In 2021, he joined the Foundation of Research & Technology – Hellas, where he heads the laboratory on Human Genetics and Precision Medicine and serves as Head of Genetics at Henry Dunant Hospital in Greece.